Saint-Sulpice, Switzerland

Claude Claret

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Nice, FR (2017 - 2019)
  • Saint Sulpice, CH (2021 - 2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Claude Claret: Innovator in Ophthalmic Solutions

Introduction

Claude Claret is a notable inventor based in Saint-Sulpice, Switzerland. He has made significant contributions to the field of ophthalmology, particularly through his innovative patents. With a total of 6 patents to his name, Claret has focused on developing solutions that address various ocular conditions.

Latest Patents

Among his latest inventions is a hyperosmolar composition of hyaluronic acid. This invention is designed for the treatment of corneal edema, providing a novel approach to managing this condition. Another significant patent involves a combination of lipoic acid and taurine, which serves as an osmoprotective agent. This invention aims to prevent and treat ailments of the skin and mucous membranes associated with osmotic imbalance. The method involves applying an appropriate amount of this combination to the affected areas, showcasing Claret's commitment to improving patient care.

Career Highlights

Throughout his career, Claude Claret has worked with reputable companies such as Horus Pharma and Ophtalmis Monaco. His experience in these organizations has allowed him to refine his expertise and contribute to the development of innovative ophthalmic products.

Collaborations

Claret has collaborated with notable individuals in his field, including Martine Claret and Jean-François Rouland. These partnerships have further enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Claude Claret's work exemplifies the spirit of innovation in the medical field, particularly in ophthalmology. His patents reflect a dedication to improving treatments for ocular conditions, making a significant impact on patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…